close_bt
img
close_bt
THE ENTEROBIOME

WHO WE ARE

PATENT

PATENT

  • Serial
    Application
    Title of Invention
    Patent Number
    Registered Date
  • 1
    Metabolic disease
    · Akkermansia muciniphila EB-AMDK19 strain and use thereof
    10-2128287
    2020.06.24
  • 2
    Metabolic disease
    · Akkermansia muciniphila EB-AMDK27 strain and use thereof
    10-2128289
    2020.06.24
  • 3
    Metabolic disease
    · Novel Faecalibacterium prausnitzii strain EB-FPDK9 and use thereof
    10-2169795
    2020.10.20
  • 4
    Metabolic disease
    · Novel Faecalibacterium prausnitzii strain EB-FPDK11 and use thereof
    10-2169794
    2020.10.20
  • 5
    Atopic disease
    · Pharmaceutical composition for preventing or treating atopic disease containing Akkermansia muciniphila strain
    10-2185827
    2020.11.26
  • 6
    Atopic disease
    · Pharmaceutical composition for preventing or treating atopic disease containing Faecalibacterium prausnitzii strain
    10-2185828
    2020.11.26
  • 7
    Culture media
    · Medium supplement for high-yeild industrial culture of fastidious anaerobes and medium composition ontaining the same
    10-2222953
    2021.02.25
  • 8
    Culture media
    · The composition of culture media for Faecalibacterium prausnitzii
    10-2245415
    2021.04.22
  • 9
    Metabolic disease
    · Composition comprising Orlistat and Akkermansia muciniphila EB-AMDK19
    10-2271821
    2021.06.25
  • 10
    Muscle atrophy
    · Pharmaceutical composition for preventing or treating muscle atrophy comprising Faecalibacterium prausnitzii strain
    10-2272616
    2021.06.29
  • 11
    Muscle atrophy
    · Pharmaceutical composition for preventing or treating muscle atrophy comprising Akkermansia muciniphila strain
    10-2329853
    2021.11.17
  • 12
    Culture media
    · The composition of culture media for Faecalibacterium prausnitzii (New)
    10-2359617
    2022.02.03